RSP Systems
Signal active
Organization
Contact Information
Overview
RSP Systems is developing a non-invasive glucose monitor, GlucoBeam(R), which will ease the lives of people with diabetes world-wide by providing convenient, pain-free glucose monitoring.
About
Industries
Biotechnology, Health Care, Medical, Medical Device, Health Diagnostics
Founded
2006
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
RSP Systems headquartered in Europe, operates in the Biotechnology, Health Care, Medical, Medical Device, Health Diagnostics sector. The company focuses on Biotechnology and has secured $7.9B in funding across 180 round(s). With a team of 11-50 employees, RSP Systems is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - RSP Systems, raised $5.1M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
9
Investors
3
Lead Investors
0
Total Funding Amount
$43.9M
Details
7
RSP Systems has raised a total of $43.9M in funding over 7 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Late Stage Venture | 7.3M | ||
| 2019 | Early Stage Venture | 3.1M | ||
| 2006 | Seed | 2.6M | ||
| 2016 | Early Stage Venture | 5.1M |
Investors
RSP Systems is funded by 7 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Georg von Werz | - | FUNDING ROUND - Georg von Werz | 5.1M |
| Jens Ulrik Holst | - | FUNDING ROUND - Jens Ulrik Holst | 5.1M |
| RSP Systems | - | FUNDING ROUND - RSP Systems | 5.1M |
| Roland Berger | - | FUNDING ROUND - Roland Berger | 5.1M |
Recent Activity
There is no recent news or activity for this profile.